Freemont Management »

BioMarin Pharmaceutical shares owned by Freemont Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Freemont Management from 13F filings

Historical chart of Freemont Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Freemont Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Freemont Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.4M 67k 96.42
2023-09-30 $5.9M 67k 88.48
2023-06-30 $6.8M 78k 86.68

More positions owned by Freemont Management

Microsoft Corporation Common Stock (MSFT)
Alphabet Class A Common Stock (GOOGL)
NVIDIA Corporation Common Stock (NVDA)
EOG Resources Common Stock (EOG)
RTX Corporation Common Stock (RTX)
Apple Common Stock (AAPL)
Barrick Gold Corporation Call
ON Semiconductor Corporation Common Stock (ON)
Amazon.com Common Stock (AMZN)
Cheniere Energy Common Stock (LNG)
Vertex Pharmaceuticals Incorporated Common Stock (VRTX)
Chevron Corporation Call
Adobe Common Stock (ADBE)
Barrick Gold Corporation Common Stock (GOLD)
Broadcom Common Stock (AVGO)

View all positions for Freemont Management

Top funds holding BioMarin Pharmaceutical

PRIMECAP Management Company
Vanguard Group
Dodge & Cox
Barclays
Viking Global Investors
venBio Select Advisor
Deutsche Bank Aktiengesellschaft
Norges Bank Investment Management
Elliott Investment Management
Henderson Group
Bank of New York Mellon
Jpmorgan Chase & Co
Bank of America Corporation
Nomura Holdings
Parnassus Investments

View all funds holding BioMarin Pharmaceutical